Overcoming drug-resistant tumors with selection gene drives.

IF 11.1 Q1 CELL BIOLOGY Cell genomics Pub Date : 2024-09-11 DOI:10.1016/j.xgen.2024.100653
Hui Wang, Mingqi Xie
{"title":"Overcoming drug-resistant tumors with selection gene drives.","authors":"Hui Wang, Mingqi Xie","doi":"10.1016/j.xgen.2024.100653","DOIUrl":null,"url":null,"abstract":"<p><p>Drug resistance is a major hurdle prohibiting effective treatment of many diseases, including cancer. Using model-guided designs, Leighow et al.<sup>1</sup> engineered a dual-switch selection gene drive system custom designed to combat drug-resistant tumors. By demonstrating remarkable killing efficacies in preclinical models using human non-small lung cancer cells in vitro and in mice, this work describes an attractive mindset to develop next-generation anticancer therapies.</p>","PeriodicalId":72539,"journal":{"name":"Cell genomics","volume":null,"pages":null},"PeriodicalIF":11.1000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480841/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell genomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.xgen.2024.100653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Drug resistance is a major hurdle prohibiting effective treatment of many diseases, including cancer. Using model-guided designs, Leighow et al.1 engineered a dual-switch selection gene drive system custom designed to combat drug-resistant tumors. By demonstrating remarkable killing efficacies in preclinical models using human non-small lung cancer cells in vitro and in mice, this work describes an attractive mindset to develop next-generation anticancer therapies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用选择基因驱动克服耐药性肿瘤。
耐药性是阻碍包括癌症在内的许多疾病有效治疗的主要障碍。Leighow 等人1 利用模型指导设计,设计了一种双开关选择基因驱动系统,专门用于对抗耐药性肿瘤。通过在体外和小鼠体内使用人类非小肺癌细胞的临床前模型中展示出显著的杀伤效果,这项工作描述了一种开发下一代抗癌疗法的诱人思路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.10
自引率
0.00%
发文量
0
期刊最新文献
AI-empowered perturbation proteomics for complex biological systems. Genetics of Latin American Diversity Project: Insights into population genetics and association studies in admixed groups in the Americas. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data. Single-cell multi-modal integrative analyses highlight functional dynamic gene regulatory networks directing human cardiac development. Analysis of single-cell CRISPR perturbations indicates that enhancers predominantly act multiplicatively.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1